Dr. Ginna G. Laport M.D.?
Update this Profile
Dr. Ginna G. Laport M.D., Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Ginna G. Laport M.D.

Hematologist-Oncologist | Hematology & Oncology

300 Pasteur Dr Rm H3249 Stanford CA, 94305
Write A Review

About

Dr. Ginna Laport is a hematologist oncologist practicing in Stanford, CA. Dr. Laport specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

U of Tx Med Sch At Houston, Houston Tx 1990

University of Texas At Houston / Medical School At Houston 1990

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM

Provider Details

FemaleEnglish 27 years of experience

Expert Publications

Data provided by the National Library of Medicine

Clinical Trials

Fellowships

  • Stanford University School of Medicine,Stanford, Ca, United States   1994

Publications

  • Jourl of clinical oncologyAutologous or reduced2014
  • BRITISH JOURL OF HAEMATOLOGYAutologous haematopoietic cell transplantation for non2013
  • JOURL OF CLINICAL ONCOLOGYHematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma2013
  • JOURL OF CLINICAL ONCOLOGYGraft-Versus-Host Disease2013
  • Kate, A. S., Efron, B., Chhabra, S., Kohrt, H., Shizuru, J. A., LaportOutcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid2013
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAlterte Donor Hematopoietic Cell Transplantation2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONFollicular Lymphoma: Prognostic Factors, Conventiol Therapies2012
  • Hari, P., Pasquini, M. C., Logan, B. R., Stadtmauer, E. A., Krishn, A.Immunoglobulin Free Light Chain (FLC) and Heavy Chain2011
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONLong-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning2011
  • HAEMATOLOGICA-THE HEMATOLOGY JOURLNon-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment2011
  • BONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
  • ik, S. G., Negrin, R., Laport, G., Miklos, D., Shizuru, J., Arai, S., Long-term outcomes of high-dose therapy using busulfan, etoposide0
  • NEW ENGLAND JOURL OF MEDICINEProtective conditioning for acute graft-versus-host disease2005
  • LEUKEMIA RESEARCHMultiple unrelated clol abnormalities2004
  • JOURL OF HEMATOTHERAPY & STEM CELL RESEARCHSoluble interleukin-2 receptor concentration as a biochemical indicator for acute graft2000
  • SEMIRS IN ONCOLOGYThe role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma1998
  • SEMIRS IN ONCOLOGYTreatment of adult acute lymphoblastic leukemia1997
  • Biology of blood and marrow transplantationTotal lymphoid irradiation-antithymocyte globulin conditioning2014
  • Journal of clinical oncologyAutologous or reduced2014
  • BLOODProspective cohort study comparing intravenous busulfan to total body irradiation2013
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONSimplified Validated Prognostic Model for Progression2013
  • BRITISH JOURNAL OF HAEMATOLOGYAutologous haematopoietic cell transplantation for non2013
  • JOURNAL OF CLINICAL ONCOLOGYHematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma2013
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONImpact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation2013
  • JOURNAL OF CLINICAL ONCOLOGYGraft-Versus-Host Disease2013
  • Kanate, A. S., Efron, B., Chhabra, S., Kohrt, H., Shizuru, J. A., LapoOutcomes After Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation with Total Lymphoid2013
  • Benjamin, J., Chhabra, S., Kohrt, H., Laport, G. G., Arai, S., JohnstoTLI-ATG Conditioning and Allogeneic Transplantation for Patients with MDS and MPN2013
  • Benjamin, J., Chhabra, S., Kohrt, H. E., Laport, G. G., Arai, S., JohnNon-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic0
  • BLOODConditioning regimens for allotransplants for diffuse large B-cell lymphoma2012
  • BONE MARROW TRANSPLANTATIONPalifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAlternate Donor Hematopoietic Cell Transplantation2012
  • BLOODProphylactic rituximab after allogeneic transplantation decreases B2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONTandem Transplantation for Follicular Lymphoma: The Best of Both Worlds?2012
  • BONE MARROW TRANSPLANTATIONTandem chemo-mobilization followed by high2012
  • BONE MARROW TRANSPLANTATIONSirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative2012
  • Hematology / the Education Program of the American Society of HematoloChanging role of stem cell transplantation in follicular lymphoma.2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONFollicular Lymphoma: Prognostic Factors, Conventional Therapies2012
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONLong-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy2012
  • LANCET ONCOLOGYAutologous haemopoietic stem2011
  • Hari, P., Pasquini, M. C., Logan, B. R., Stadtmauer, E. A., Krishnan, Immunoglobulin Free Light Chain (FLC) and Heavy Chain2011
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONLong-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning2011
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAdoptive Immunotherapy with Cytokine2011
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNALNon-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment2011
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAutologous versus Reduced2011
  • Mueller, A. M., Kohrt, H. E., Laport, G. G., Negrin, R. S., Cha, S., WLONG-TERM FOLLOW-UP OF METASTATIC BREAST CANCER PATIENTS RECEIVING HIGHLY PURIFIED AUTOLOGOUS2011
  • BONE MARROW TRANSPLANTATIONLong-term outcomes in patients with high2011
  • CURRENT OPINION IN ONCOLOGYPeripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy2010
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONPhase I/II Trial of GN-BVC2010
  • Li, L., Kohrt, H., Heish, S., Alizadeh, A., Laport, G., Shizuru, J., NNoninvasive Prediction of Graft-Versus2010
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation2010
  • BONE MARROW TRANSPLANTATIONLong-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged2010
  • BLOODTLI and ATG conditioning with low risk of graft-versus2009
  • Naik, S. G., Negrin, R., Laport, G., Miklos, D., Shizuru, J., Arai, S.Long-term outcomes of high-dose therapy using busulfan, etoposide0
  • Kohrt, H., Turnbull, B., Laport, G., Miklos, D., Shizuru, J., JohnstonOutcomes Following Allogeneic Hematopoietic Cell Transplantation2008
  • Arai, S., Sahaf, B., Jones, C., Zhender, J., Lowsky, R., Strober, S., Prophylactic Rituximab after Reduced Intensity Conditioning Transplantation Results2008
  • Arai, S., Letsinger, R., Johnston, L., Laport, G., Lowsky, R., Miklos,Phase I/II Trial of a Novel Gemcitabine2008
  • BLOODLong-term remission of Philadelphia chromosome2008
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONLong-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma2008
  • Laport, G., Bredeson, C., Tomblyn, M. R., Kahl, B. S., Goodman, S. A.,Autologous versus reduced0
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONReduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult2008
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONControversies in lymphoma2008
  • LEUKEMIA & LYMPHOMAAllogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review2008
  • Arai, S., Sheehan, K., Moore, S., Laport, G., Johnston, L., Lowsky, R.Autologous cytokine-induced killer cells as post-transplant cellular immunotherapy2007
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONMantle cell lymphoma in first complete remission2007
  • Arai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., Rituximab infusion two months after total lymphoid irradiation-antithymocyte globulin2007
  • Arai, S., Sahaf, B., Jones, C., Zehnder, J., Lowsky, R., Strober, S., Rituximab infusion two months after nonmyeloablative transplantation maintains B2006
  • Lowsky, R., Stockert-Goldstein, K., Laport, G., Miklos, D., Arai, S., Clinical outcomes following allogeneic hematopoietic cell transplantation2006
  • Laport, G. G., Sheehan, K., Lowsky, R., Shizuru, J. A., Stockerl-GoldsCytokine induced killer2006
  • Cao, T. M., Stockerl-Goldstein, K. E., Cao, P. D., Laport, G. G., SheeHigh dose therapy and autologous hematopoietic cell transplantation for primary refractory diffuse2006
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONHigh-dose carmustine, etoposide2006
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONThe role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma2006
  • Lowsky, R., Heydari, K., Sahaf, B., Shizuru, J., Laport, G., Johnston,Haploidentical non-myeloablative allogeneic hematopoietic cell transplantation2005
  • BONE MARROW TRANSPLANTATIONRhabdomyolysis after concomitant use of cyclosporine2005
  • NEW ENGLAND JOURNAL OF MEDICINEProtective conditioning for acute graft-versus-host disease2005
  • Arai, S., Negrin, R., Blume, K., Johnston, L., Laport, G., Lowsky, R.,A phase I trial with extended cohort of gemcitabine2005
  • BLOODEngraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell2005
  • EXPERIMENTAL HEMATOLOGYCD34, CD49 and CD8 cell doses do not influence engraftment2005
  • Cao, T. M., Shizuru, J. A., Wong, R. M., Sheehan, K., Laport, G. G., SEngraftment and survival following non-myeloablative allogeneic peripheral blood hematopoietic cell2004
  • LEUKEMIA RESEARCHMultiple unrelated clonal abnormalities2004
  • Lowsky, R., Jones, S. D., Mitra, S., Shizuru, J. A., Laport, G. G., StNon-myeloablative conditioning with total lymphoid irradiation (TLI)2003
  • BLOODAdoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed2003
  • Current hematology reportsNonmyeloablative allogeneic stem cell transplantation for acute leukemia.2003
  • BONE MARROW TRANSPLANTATIONA phase II trial of docetaxel for peripheral blood stem cell mobilization for patients2001
  • BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAllogeneic cell therapy for patients who relapse after autologous stem cell transplantation2001
  • JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCHSoluble interleukin-2 receptor concentration as a biochemical indicator for acute graft2000
  • BONE MARROW TRANSPLANTATIONA dose escalation study of total body irradiation followed by high-dose etoposide2000
  • CYTOTHERAPYTransplantation with low-density autologous PBSC prepared with BDS60 for women with stage II2000
  • SEMINARS IN ONCOLOGYThe role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma1998
  • BONE MARROW TRANSPLANTATIONHigh-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer1998
  • SEMINARS IN ONCOLOGYTreatment of adult acute lymphoblastic leukemia1997

Experience & Accolades

  • Professor of Medicine (Blood and Marrow Transplantation)the Stanford University Medical Center

Dr. Ginna G. Laport M.D.'s Practice location

Dr. Ginna Laport, MD

300 Pasteur Dr Rm H3249 -
Stanford, CA 94305
Get Direction
New patients: 650-723-0822
Fax: 650-725-8950

Dr. Ginna G. Laport M.D.'s reviews

(0)
Write Review

Recommended Articles

  • The Blow Self-Image Can Take During Lymphoma Treatment

    Many who have endured cancer treatment experience a blow to their self image, and cease to recognize the person looking back at them in the mirror.However, it does not have to be that way! Here are some of the most common changes, and how to cope with them.Skin changesYou may begin to see your skin...

  • The Lymphoma Research Foundation's Light it Red for Lymphoma Night

    Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

  • Little Boy Tugs at Heartstrings of Entire Community: Be the Match!

    Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...

  • 7-year-old with Lymphoma Joins and Inspires Lacrosse Team

    Sports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...

  • Exercise Proven to Help Lymphoma Patients

    People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...

  • How This Survivor Star Beat Hodgkin Lymphoma—Twice

    Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

Nearby Providers

See all nearby providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head east 891 ft
Turn right onto Pasteur Drive 698 ft
You have arrived at your destination, on the right

1590 ftSee direction

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2864 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

3.5 miSee direction

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head east 891 ft
Turn right onto Pasteur Drive 754 ft
Turn right onto Welch Road 2045 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left

4108 ftSee direction